Postpartum acquired factor VIII inhibitors
- 25 July 2006
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 81 (10), 768-773
- https://doi.org/10.1002/ajh.20702
Abstract
The development of factor VIII autoantibodies is a rare but severe complication of pregnancy. Although the natural history of postpartum acquired hemophilia A is usually benign, with a high percentage of spontaneous remissions and a low mortality, its quick recognition is important to control bleeding episodes. Based on an analysis of the literature, this review presents the current knowledge on the pathogenesis, diagnosis, epidemiology, natural history, clinical manifestations, and therapeutic management of postpartum acquired hemophilia A. Am. J. Hematol., 2006.Keywords
This publication has 67 references indexed in Scilit:
- Acquired hemophilia A: A concise reviewAmerican Journal of Hematology, 2005
- Treatment of acquired hemophilia by the Bonn-Malmö Protocol: documentation of an in vivo immunomodulating conceptBlood, 2005
- Aquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisoneAmerican Journal of Hematology, 2002
- Postpartum Acquired Hemophilia (Factor VIII Inhibitors): A Case Report and Review of the LiteratureObstetrical & Gynecological Survey, 2000
- Postpartum acquired factor VIII inhibitors: Results of a surveyAmerican Journal of Hematology, 1998
- Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitorEuropean Journal of Haematology, 1997
- Acquired haemophilia: experience of two Italian centres with 17 new casesHaemophilia, 1997
- Severe intracranial hemorrhage in a newborn infant with transplacental transfer of an acquired factor VIII:C inhibitorThe Journal of Pediatrics, 1995
- Post-Partum Treatment of a Patient with a Factor VIII InhibitorNew England Journal of Medicine, 1981
- Corticosteroid Therapy for Acquired F VIII:C InhibitorsBritish Journal of Haematology, 1981